id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2018-N-3236-0003,FDA,FDA-2018-N-3236,Advisory Committee; Oncologic Drugs Advisory Committee; Renewal,Notice,Notice of Renewal,2024-11-27T05:00:00Z,2024,11,2024-11-27T05:00:00Z,,2024-11-27T15:34:59Z,2024-27797,0,0,090000648683b12a